Literature DB >> 321707

Therapy for experimental intraabdominal sepsis: comparison of four cephalosporins with clindamycin plus gentamicin.

T J Louie, A B Onderdonk, S L Gorbach, J G Bartlett.   

Abstract

An experimental model of intraabdominal sepsis in rats was used for evaluation of treatment with four cephalosporins: cephalothin, cefazolin, cefoxitin, and cefamandole. Doses were 115 mg of each of the cephalosporins/kg and, in additional experiments, 350 mg of cephalothin or cefazolin/kg. Response to treatment was evaluated by mortality rate and the incidence of intraabdominal abscess. All four cephalosporins and gentamicin produced a similar reduction in mortality rates. There was a marked variation in incidence of abscess dependent upon the cephalosporin selected and the dosage tested. Regimens most effective in reducing abscesses were clindamycin, low-dose cefoxitin, or high-dose cephalothin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 321707     DOI: 10.1093/infdis/135.supplement.s18

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

Review 1.  Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection.

Authors:  J L Ho; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

Review 2.  Cephalosporins in surgery. Prophylaxis and therapy.

Authors:  D W McEniry; S L Gorbach
Journal:  Drugs       Date:  1987       Impact factor: 9.546

3.  Biographical Feature: Andrew B. Onderdonk, Ph.D.

Authors:  Alexander J McAdam
Journal:  J Clin Microbiol       Date:  2021-09-15       Impact factor: 5.948

4.  Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.

Authors:  H Thadepalli; S V Gollapudi; S K Chuah
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

5.  Inactivation of cephalosporins by Bacteroides.

Authors:  F P Tally; J P O'Keefe; N M Sullivan; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.